Suppr超能文献

血浆中高分子量激肽原、凝血因子 XII 和纤维蛋白原在界面处的相互作用。

Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces.

作者信息

Vroman L, Adams A L, Fischer G C, Munoz P C

出版信息

Blood. 1980 Jan;55(1):156-9.

PMID:7350935
Abstract

Using ellipsometry, anodized tantalum interference color, and Coomassie blue staining in conjunction with immunologic identification of proteins adsorbed at interfaces, we have previously found that fibrinogen is the main constituent deposited by plasma onto many man-made surfaces. However, the fibrinogen deposited from normal plasma onto glass and similar wettable materials is rapidly modified during contact activation until it can no longer be identified antigenically. In earlier publications, we have called this modification of the fibrinogen layer "conversion," to indicate a process of unknown nature. Conversion of adsorbed fibrinogen by the plasma was not accompanied by marked change in film thickness, so that we presumed that this fibrinogen was not covered but replaced by other protein. Conversion is now showen to be markedly delayed in plasma lacking high molecular weight kininogen, slightly delayed in plasma lacking factor XII, and normal in plasma that lack factor XI or prekallikrein. We conclude that intact plasma will quickly replace the fibrinogen it has deposited on glass-like surfaces by high molecular weight kininogen and, to a smaller extent, by factor XII. Platelets adhere preferentially to fibrinogen-coated surfaces; human platelets adhere to hydrophobic nonactivating surfaces, since on these, adsorbed firbinogen is not exchanged by the plasma. The adsorbed fibrinogen will be replaced on glass-like surfaces during surface activation of clotting, and platelets failing to find fibrinogen will not adhere.

摘要

我们此前通过椭圆偏振光法、阳极氧化钽干涉色以及考马斯亮蓝染色,并结合对吸附在界面上的蛋白质进行免疫学鉴定,发现纤维蛋白原是血浆沉积在许多人造表面上的主要成分。然而,从正常血浆沉积到玻璃及类似可湿性材料上的纤维蛋白原在接触激活过程中会迅速发生改变,直至无法通过抗原学方法鉴定。在早期的出版物中,我们将纤维蛋白原层的这种改变称为“转化”,以表明这是一个性质不明的过程。血浆对吸附的纤维蛋白原的转化并未伴随着膜厚度的显著变化,因此我们推测这种纤维蛋白原并未被覆盖,而是被其他蛋白质所取代。现已表明,在缺乏高分子量激肽原的血浆中,转化明显延迟;在缺乏因子 XII 的血浆中,转化稍有延迟;而在缺乏因子 XI 或前激肽释放酶的血浆中,转化则正常。我们得出结论,完整的血浆会迅速用高分子量激肽原,以及在较小程度上用因子 XII,来取代其沉积在玻璃样表面上的纤维蛋白原。血小板优先黏附于纤维蛋白原包被的表面;人类血小板黏附于疏水性非激活表面,因为在这些表面上,吸附的纤维蛋白原不会被血浆置换。在凝血的表面激活过程中,吸附的纤维蛋白原会在玻璃样表面上被取代,而未能找到纤维蛋白原的血小板将不会黏附。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验